(Q53300566)

English

Biomarkers in clinical trials of Alzheimer disease (AD): what is expected from regulatory agencies?

scientific article published in April 2009

In more languages
default values for all languages
No label defined

No description defined

Statements

Biomarkers in clinical trials of Alzheimer disease (AD): what is expected from regulatory agencies? (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit